ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Aegerion製藥
1.97
0.0000
成交量：
- -
成交額：
- -
市值：
5,820.38萬
市盈率：
-0.33
高：
1.97
開：
1.97
低：
1.97
收：
1.97
52周最高：
10.85
52周最低：
1.23
股本：
2,954.51萬
流通股本：
1,428.97萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-5.9700
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Aegerion製藥
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.aegerion.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
Aegerion Pharmaceuticals, Inc.是一家生物製藥公司,致力於為那些衰弱的、患有致命罕見疾病的人開發新奇的，並且能夠挽救生命的治療方法並將其用於商業用途。公司的第一個產品JUXTAPID，在2012年12月21日得到了美國食品和藥物管理局的營銷批准，並作為對低脂肪飲食和其他降脂治療的補充，包括低密度脂蛋白(LDL)血清法，如果可用，可降低純合子家族性高膽固醇血症患者(HoFH)的低密度脂蛋白膽固醇(低密度)、總膽固醇(TC)、載脂蛋白B(B朊)和非高密度脂蛋白膽固醇(non-HDL-C)。2013年1月底，該公司在美國推出了JUXTAPID。在2012年的第一季度,它向歐洲藥品局(EMA)提交了營銷授權申請(MAA)請求批准上市，作為低脂肪飲食和其他降脂治療的輔助，在用或是不用血清法的條件下減少患有血症的成年人體內的低密度脂蛋白、TC、載脂蛋白B和甘油三酯(TG)。公司於2005年2月在特拉華州法律下成立。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AEGR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"AEGR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEGR\",,,,,undefined,":{"symbol":"AEGR","market":"US","secType":"STK","nameCN":"Aegerion製藥","latestPrice":1.97,"timestamp":1480539600000,"preClose":1.97,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":14289727,"shares":29545088,"eps":-5.97,"marketStatus":"休市中","change":0,"latestTime":"11-30 16:00:00 EST","open":1.97,"high":1.97,"low":1.97,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.97,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1287720000000,"exchange":"NASDAQ","adjPreClose":1.97,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AEGR\",,,,,undefined,":{"symbol":"AEGR","floatShares":14289727,"roa":"--","roe":"--","lyrEps":0,"shares":29545088,"dividePrice":0,"high":1.97,"amplitude":0,"preClose":1.97,"low":1.97,"week52Low":1.23,"pbRate":"--","week52High":10.85,"institutionHeld":0,"latestPrice":1.97,"eps":-5.97,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.97,"open":1.97,"prevYearClose":1.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AEGR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-03","symbol":"AEGR","fiscalQuarterEnding":null,"expectedEps":-0.67,"name":null,"time":"","type":"earning","dateTimestamp":1478145600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2016-08-09","symbol":"AEGR","fiscalQuarterEnding":null,"expectedEps":-0.25,"name":null,"time":"","type":"earning","dateTimestamp":1470715200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2016-05-16","symbol":"AEGR","fiscalQuarterEnding":null,"expectedEps":-1.85,"name":null,"time":"盤後","type":"earning","dateTimestamp":1463371200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-02-25","symbol":"AEGR","fiscalQuarterEnding":null,"expectedEps":-0.97,"name":null,"time":"盤後","type":"earning","dateTimestamp":1456376400000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2015-11-09","symbol":"AEGR","fiscalQuarterEnding":null,"expectedEps":-0.51,"name":null,"time":"盤後","type":"earning","dateTimestamp":1447045200000,"reportTimeType":"post","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AEGR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AEGR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.aegerion.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Aegerion Pharmaceuticals, Inc.是一家生物製藥公司,致力於為那些衰弱的、患有致命罕見疾病的人開發新奇的，並且能夠挽救生命的治療方法並將其用於商業用途。公司的第一個產品JUXTAPID，在2012年12月21日得到了美國食品和藥物管理局的營銷批准，並作為對低脂肪飲食和其他降脂治療的補充，包括低密度脂蛋白(LDL)血清法，如果可用，可降低純合子家族性高膽固醇血症患者(HoFH)的低密度脂蛋白膽固醇(低密度)、總膽固醇(TC)、載脂蛋白B(B朊)和非高密度脂蛋白膽固醇(non-HDL-C)。2013年1月底，該公司在美國推出了JUXTAPID。在2012年的第一季度,它向歐洲藥品局(EMA)提交了營銷授權申請(MAA)請求批准上市，作為低脂肪飲食和其他降脂治療的輔助，在用或是不用血清法的條件下減少患有血症的成年人體內的低密度脂蛋白、TC、載脂蛋白B和甘油三酯(TG)。公司於2005年2月在特拉華州法律下成立。","exchange":"NASDAQ","name":"Aegerion製藥","nameEN":"Aegerion Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AEGR\",market:\"US\",,,undefined,":null}}